Multiple squamous cell carcinomas following introduction of nilotinib

Peters, P., Rabbolini, D., Sinnya, S., Khosrotehrani, K. and Wagner, G. (2014) Multiple squamous cell carcinomas following introduction of nilotinib. Clinical and Experimental Dermatology, 39 7: 791-794. doi:10.1111/ced.12388

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads

Author Peters, P.
Rabbolini, D.
Sinnya, S.
Khosrotehrani, K.
Wagner, G.
Title Multiple squamous cell carcinomas following introduction of nilotinib
Journal name Clinical and Experimental Dermatology   Check publisher's open access policy
ISSN 0307-6938
Publication date 2014
Sub-type Article (original research)
DOI 10.1111/ced.12388
Volume 39
Issue 7
Start page 791
End page 794
Total pages 4
Place of publication West Sussex, England, U.K.
Publisher Wiley-Blackwell Publishing Ltd.
Collection year 2015
Language eng
Subject 2708 Dermatology
Abstract Background: Nilotinib is a second generation tyrosine kinase inhibitor, used in the treatment of chronic myelogenous leukaemia (CML). Methods: We assessed a 72-year-old woman who was treated with nilotinib for CML. Results: During the year following commencement of nilotinib, the patient developed eight squamous cell carcinomas (SCCs) on her legs. Conclusions: Development of SCC is a previously unreported adverse reaction to nilotinib.
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Sun, 19 Oct 2014, 01:00:22 EST by System User on behalf of School of Medicine